- Home
- LYRA vs EPWK Comparison
LYRA vs EPWK Comparison
Compare LYRA & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- EPWK
- Stock Information
- Founded
- LYRA 2005
- EPWK 2011
- Country
- LYRA United States
- EPWK China
- Employees
- LYRA N/A
- EPWK N/A
- Industry
- LYRA Medical/Dental Instruments
- EPWK
- Sector
- LYRA Health Care
- EPWK
- Exchange
- LYRA Nasdaq
- EPWK Nasdaq
- Market Cap
- LYRA 11.3M
- EPWK 9.5M
- IPO Year
- LYRA 2020
- EPWK 2025
- Fundamental
- Price
- LYRA $6.85
- EPWK $0.30
- Analyst Decision
- LYRA Hold
- EPWK
- Analyst Count
- LYRA 1
- EPWK 0
- Target Price
- LYRA $16.00
- EPWK N/A
- AVG Volume (30 Days)
- LYRA 14.2K
- EPWK 1.1M
- Earning Date
- LYRA 08-12-2025
- EPWK 05-27-2025
- Dividend Yield
- LYRA N/A
- EPWK N/A
- EPS Growth
- LYRA N/A
- EPWK N/A
- EPS
- LYRA N/A
- EPWK N/A
- Revenue
- LYRA $770,000.00
- EPWK $20,164,008.00
- Revenue This Year
- LYRA N/A
- EPWK N/A
- Revenue Next Year
- LYRA $123.46
- EPWK N/A
- P/E Ratio
- LYRA N/A
- EPWK N/A
- Revenue Growth
- LYRA N/A
- EPWK 10.25
- 52 Week Low
- LYRA $3.81
- EPWK $0.29
- 52 Week High
- LYRA $37.50
- EPWK $26.00
- Technical
- Relative Strength Index (RSI)
- LYRA 42.34
- EPWK N/A
- Support Level
- LYRA $6.91
- EPWK N/A
- Resistance Level
- LYRA $7.50
- EPWK N/A
- Average True Range (ATR)
- LYRA 0.33
- EPWK 0.00
- MACD
- LYRA 0.06
- EPWK 0.00
- Stochastic Oscillator
- LYRA 16.18
- EPWK 0.00
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.